Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana, Billings
Bozeman Health Deaconess Hospital - Bozeman Health Cancer Center, Bozeman
Bozeman Health Deaconess Hospital - Bozeman Health Clinical Research, Bozeman
и уште 1

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07144280

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

SCL Health - Montana, Billings
SCL Health - Montana, Billings

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06758401

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

Community Hospital of Anaconda, Anaconda
Billings Clinic Cancer Center, Billings
Bozeman Health Deaconess Hospital, Bozeman
и уште 6

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 24.9.2026 · NCT03191149

Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

Logan Health Research, Kalispell

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 15.9.2026 · NCT06899126

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

St. Vincent Frontier Cancer Center-Research ( Site 0105), Billings

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 8.9.2026 · NCT06345729

Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

St. Vincent Frontier Cancer Center, Billings

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 26.8.2026 · NCT07288177

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

Intermountain Health - St. Vincent Frontier Cancer Center, Billings

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 30.6.2026 · NCT06162221

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Community Hospital of Anaconda, Anaconda
Billings Clinic Cancer Center, Billings
Bozeman Health Deaconess Hospital, Bozeman
и уште 3

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 3.6.2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Community Hospital of Anaconda, Anaconda
Billings Clinic Cancer Center, Billings
Bozeman Health Deaconess Hospital, Bozeman
и уште 3

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 6.5.2026 · NCT06116682

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Community Hospital of Anaconda, Anaconda
Billings Clinic Cancer Center, Billings
Bozeman Health Deaconess Hospital, Bozeman
и уште 3

Се регрутираФаза 2

18 Minutes · Сите полови · Ажурирано 5.5.2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Community Hospital of Anaconda, Anaconda
Billings Clinic Cancer Center, Billings
Bozeman Health Deaconess Hospital, Bozeman
и уште 3

Се регрутираФаза 2/3

Возраст 18 и постари · Сите полови · Ажурирано 5.5.2026 · NCT06616584

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Community Hospital of Anaconda, Anaconda
Billings Clinic Cancer Center, Billings
Montana Cancer Consortium NCORP, Billings
и уште 5

Се регрутираНабљудувачка студија

Возраст 18 и постари · Сите полови · Ажурирано 17.3.2026 · NCT06418204

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Billings

Се регрутираНабљудувачка студија

Сите возрасти · Сите полови · Ажурирано 28.10.2025 · NCT03452774

Од ClinicalTrials.gov, податоци преземени 5.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.